Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Deutsche Bank’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-128	Closed	-$12K	–	4231
2021 Q4	$12K	Sell	128 -112	-47%	-$10.3K	﹤0.01%	4156
2021 Q3	$21K	Buy	+240	New	+$18.6K	﹤0.01%	4231
2020 Q4	–	Sell	-38	Closed	-$2K	–	4466
2020 Q3	$2K	Buy	+38	New	+$2.59K	﹤0.01%	4288
2019 Q4	–	Sell	-404	Closed	-$25K	–	5067
2019 Q3	$25K	Sell	404 -26	-6%	-$1.63K	﹤0.01%	4238
2019 Q2	$30K	Hold	430	–	–	﹤0.01%	4697
2019 Q1	$33K	Buy	+430	New	+$32.6K	﹤0.01%	4682
2018 Q3	–	Sell	-71	Closed	-$9K	–	5459
2018 Q2	$9K	Sell	71 -593	-89%	-$66.2K	﹤0.01%	5164
2018 Q1	$68K	Buy	664 +311	+88%	+$30.8K	﹤0.01%	4648
2017 Q4	$30K	Buy	+353	New	+$30.6K	﹤0.01%	4578
2013 Q4	–	Sell	-128	Closed	-$1K	–	5565
2013 Q3	$1K	Buy	+128	New	+$3.6K	﹤0.01%	5417

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's LGND Position: Q2 2026 in Review

Deutsche Bank reduced its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, selling an estimated $13.3M and leaving 249,611 shares worth $78.9M. The position accounts for 0.02% of the portfolio, ranked #558.

Deutsche Bank first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $115M in Q2 2018. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Deutsche Bank held 249,611 shares of Ligand Pharmaceuticals worth $78.9M as of Q2 2026.
Deutsche Bank sold 56,500 Ligand Pharmaceuticals shares in Q2 2026, an estimated $13.3M.
Ligand Pharmaceuticals made up 0.02% of Deutsche Bank's portfolio in Q2 2026, its #558 holding.
Deutsche Bank first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Deutsche Bank's Ligand Pharmaceuticals position peaked at $115M in Q2 2018.
416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.